Article

Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin.

Stéphane Vigouroux, Reza Tabrizi, Cyril Melot, Joëlle Coiffard, Xavier Lafarge, Gérald Marit, Krimo Bouabdallah, Arnaud Pigneux, Thibaut Leguay, Marie-Sarah Dilhuydy, Anna Schmitt, Jean-Michel Boiron, Noël Milpied

Service des Maladies du Sang, CHU Haut-Lévêque , Bordeaux , France.

Leukemia & lymphoma (impact factor: 2.4). 08/2011; 53(1):162-5. DOI:10.3109/10428194.2011.604754 pp.162-5

Source: PubMed

0 0

0 Bookmarks

29 Views

Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin.

View other sources

Hide other sources

View other sources

Hide other sources

Similar Publications

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.

[Reduced intensity conditioning regimen for related and unrelated allogeneic peripheral blood hematopoietic stem cell transplantation in chronic myeloid leukemia.].

Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.

Xavier Lafarge

Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin.

View other sources

Hide other sources

View other sources

Hide other sources

Similar Publications

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.

[Reduced intensity conditioning regimen for related and unrelated allogeneic peripheral blood hematopoietic stem cell transplantation in chronic myeloid leukemia.].

Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.

Xavier Lafarge

Log in